Gene therapy of anti-angiogenesis by intramuscular delivery of plasmid DNA encoding IP-10 combined with gemcitabine was effective in inhibition of angiogenesis by suppressing the proliferation of endothelial cells, and induction of lymphocytes infiltration in tumor tissues and the apoptosis of tumor cells in murine models. This evidence concerns the gene CXCL10 and neoplasm.